19
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T5513 |
RO-3
|
P2X Receptor | Membrane transporter/Ion channel; Neuroscience |
RO3 是一种能透过大脑的P2X3和P2X2/3拮抗剂,口服有活性。它对人同型多聚体 P2X3和异型多聚体 P2X2/3受体的 pIC50分别为 5.9 和 7.0。 | |||
T34360 |
Ro 3-7410
Ro-3-7410 |
||
Ro 3-7410 is an active hydroxy metabolite of bufuralol. | |||
T34359 |
Ro 3-5940 HCl
Ro 3 5940 HCl |
||
Ro 3-5940 HCl is a psychoactive agent, increasing in production of serotonin in central nervous system tissue. | |||
T6312 |
R547
Ro 4584820 |
Apoptosis; GSK-3; PKA; CDK | Apoptosis; Cell Cycle/Checkpoint; PI3K/Akt/mTOR signaling; Stem Cells; Tyrosine Kinase/Adaptors |
R547 (Ro 4584820) 是一种口服有效,选择性, ATP 竞争性CDK 抑制剂,对 CDK1/cyclin B、 CDK2/cyclin E 和 CDK4/cyclin D1 作用的Ki 值分别为 2 nM、3 nM、1 nM。 | |||
T0110 |
Zalcitabine
Dideoxycytidine,ddC,扎西他滨,NSC 606170,Ro 24-2027/000,2',3'-Dideoxycytidine |
HIV Protease; Reverse Transcriptase | Microbiology/Virology; Proteases/Proteasome |
Zalcitabine (Dideoxycytidine) 是一种核苷类似物逆转录酶抑制剂,用于HIV 感染相关研究。 | |||
T0860L |
Mefloquine
Ro215998,WR 142490,Ro-215998,氟甲喹羟哌啶,Lariam,Ro 215998 |
Others | Others |
Mefloquine (Ro 215998) 是一种喹啉抗疟药,是一种抗 SARS-CoV-2 进入抑制剂。 Mefloquine 也是一种 K+ 通道 (KvQT1/minK) 拮抗剂,IC50 为 ~1 μM。它可用于疟疾、系统性红斑狼疮和癌症研究。 | |||
T30611 |
Bufuralol
Ro3-4787,Ro 3-4787,Ro-3-4787 |
||
Bufuralol is a Adrenergic Agent. | |||
T10119 |
3-O-Methyltolcapone
Ro 40-7591 |
Transferase | Metabolism |
3-O-Methyltolcapone (Ro 40-7591) is a metabolite of Tolcapone which is a potent COMT inhibitor. Tolcapone crosses the blood-brain barrier and can be used for treatment of Parkinson's disease. | |||
T19706 |
Ro 20-1724
Ro-20-1724,4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone,Ro20-1724 |
PDE | Metabolism |
Ro 20-1724 (4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone) 是 cAMP 特异性磷酸二酯酶抑制剂 b>(PDE4/PDE IV),其 Ki=1930 nM,具有神经保护作用。 | |||
T12571 |
PSI-6206 13C,d3
Sofosbuvir metabolite GS-331007 13CD3,RO-2433 13CD3,PSI-6206 13CD3,GS-331007 13CD3 |
Others | Others |
PSI-6206 13CD3 is the deuterium labeled PSI-6206. PSI-6206 is a potent and selective HCV NS5B polymerase inhibitor. | |||
T2087 |
AF-353
Ro-4 |
P2X Receptor | Membrane transporter/Ion channel; Neuroscience |
AF-353 (Ro-4) 是一种选择性、可口服的 P2X3/P2X2/3 受体拮抗剂,抑制人和大鼠 P2X3 的 pIC50值为 8.0,抑制人 P2X2/3 的 pIC50值为 7.3。 | |||
T1896 |
Ro 61-8048
|
Hydroxylase | Metabolism |
Ro 61-8048 是一种选择性的、口服有效的犬尿氨酸 3-羟化酶抑制剂(IC50:37 nM)。它能够导致细胞喹啉酸浓度的显著增加。 | |||
T6643 |
Ro 31-8220 Mesylate
Ro 31-8220 methanesulfonate,Bisindolylmaleimide IX,Bisindolylmaleimide IX mesylate |
PKC | Chromatin/Epigenetic; Cytoskeletal Signaling |
Ro 31-8220 Mesylate (Bisindolylmaleimide IX mesylate) 是PKC 抑制剂,对 PKCα、PKCβI、PKCβII、PKCγ、PKCε 和大鼠大脑 PKC 的IC50值为 5、24、14、27、24 和 23 nM。它还抑制 MAPKAP-K1b、MSK1、S6K1 和 GSK3β,IC50为3、8、15 和 38 nM。 | |||
T10118 |
3-O-Methyltolcapone D7
Ro 40-7591 D7 |
Transferase | Metabolism |
3-O-Methyltolcapone D7 (Ro 40-7591 D7) is a deuterium labeled 3-O-Methyltolcapone. 3-O-Methyltolcapone (Ro 40-7591) is a metabolite of Tolcapone which is a potent COMT inhibitor. Tolcapone crosses the blood-brain barrier and can be used for treatment of P | |||
T28598 |
Ro-23-9424
Ro 239424,Ro23-9424 |
||
Ro-23-9424 is a dual-action cephalosporin with a fleroxacin esterified at the 3' position and aminothiazolylmethoxyimino-type side chain at the 7 position. Ro-23-9424 has broad and potent antibacterial activity in vitro and in vivo. | |||
T28775 |
Sibrafiban
RO-48-3657/001,RO-48-3657,RO 48-3657/001 |
||
Sibrafiban (RO 48-3657) 是一种 Ro 44-3888 的口服非肽双前药,是一种选择性的糖蛋白 IIb/IIIa 受体 (glycoprotein IIb/IIIa receptor) 拮抗剂。Sibrafiban 能够抑制血小板聚集。 | |||
T21684 |
Bufuralol (hydrochloride)
|
||
Bufuralol hydrochloride (Ro 3-4787 hydrochloride) 是一种有效的非选择性,口服活性的 β-肾上腺素受体 (β-adrenoreceptor) 拮抗剂,具有部分激动剂活性。Bufuralol hydrochloride 是CYP2D6 探针的底物。 | |||
T6643L |
Ro 31-8220
|
||
Ro 31-8220 是一种有效的PKC 抑制剂,对 PKCα,PKCβI,PKCβII,PKCγ,PKCε 和大鼠大脑 PKC 的IC50值为 5,24,14,27,24 和 23 nM。Ro 31-8220还显著抑制 MAPKAP-K1b,MSK1,S6K1 和 GSK3β,IC50值分别为3,8,15,38 nM,对 MKK3,MKK4,MKK6 和 MKK7 无作用。 | |||
T71000 |
RO-5328673
|
||
RO-5328673 is a dual NK2/NK3 antagonist. O5328673. [(3)H]RO5328673 bound to a single saturable site on hNK2, hNK3 and gpNK3 with high-affinity. RO5328673 acted as an insurmountable antagonist at both human and guinea-pig NK3 receptors in the [(3)H]IP accumulation assay. In binding kinetic analyses, [(3)H]RO5328673 had fast association and dissociation rates at hNK2 while it had a fast association rate and a remarkably slow dissociation rate at gp and hNK3. In electrophysiological recordings of g... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T3915 |
Ginsenoside Ro
人参皂苷Ro,Chikusetsusaponin 5,Polysciasaponin P3,人参皂苷 Ro,Chikusetsusaponin V |
Calcium Channel; Reductase; Prostaglandin Receptor | Endocrinology/Hormones; GPCR/G Protein; Immunology/Inflammation; Membrane transporter/Ion channel; Metabolism |
Ginsenoside Ro (Chikusetsusaponin V) 能降低 TXA2产量,较弱降低 COX-1 和 TXAS 活性,具有 Ca2+拮抗剂的抗血小板作用,IC50为 155 μM。 |